159 related articles for article (PubMed ID: 16275364)
1. Evidence of remodeling in peripheral airways of patients with mild to moderate asthma: effect of hydrofluoroalkane-flunisolide.
Bergeron C; Hauber HP; Gotfried M; Newman K; Dhanda R; Servi RJ; Ludwig MS; Hamid Q
J Allergy Clin Immunol; 2005 Nov; 116(5):983-9. PubMed ID: 16275364
[TBL] [Abstract][Full Text] [Related]
2. Effect of HFA-flunisolide on peripheral lung inflammation in asthma.
Hauber HP; Gotfried M; Newman K; Danda R; Servi RJ; Christodoulopoulos P; Hamid Q
J Allergy Clin Immunol; 2003 Jul; 112(1):58-63. PubMed ID: 12847480
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of efficacy and safety of flunisolide hydrofluoroalkane for the treatment of asthma.
Corren J; Tashkin DP
Clin Ther; 2003 Mar; 25(3):776-98. PubMed ID: 12852702
[TBL] [Abstract][Full Text] [Related]
4. Effective control of asthma with hydrofluoroalkane flunisolide delivered as an extrafine aerosol in asthma patients.
Corren J; Nelson H; Greos LS; Bensch G; Goldstein M; Wu J; Wang S; Newman K
Ann Allergy Asthma Immunol; 2001 Nov; 87(5):405-11. PubMed ID: 11730183
[TBL] [Abstract][Full Text] [Related]
5. One-year trial on safety and normal linear growth with flunisolide HFA in children with asthma.
Gillman SA; Anolik R; Schenkel E; Newman K
Clin Pediatr (Phila); 2002 Jun; 41(5):333-40. PubMed ID: 12086199
[TBL] [Abstract][Full Text] [Related]
6. Flunisolide for the treatment of asthma.
Melani AS
Expert Rev Clin Pharmacol; 2014 May; 7(3):251-8. PubMed ID: 24716719
[TBL] [Abstract][Full Text] [Related]
7. Flunisolide hydrofluoroalkane with integrated spacer for treating asthma: an updated review.
Berger WE; Tashkin DP
Allergy Asthma Proc; 2015; 36(2):105-15. PubMed ID: 25635610
[TBL] [Abstract][Full Text] [Related]
8. Flunisolide HFA.
Waugh J; Goa KL
Am J Respir Med; 2002; 1(5):369-72; discussion 373. PubMed ID: 14720039
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic significance of distal airway inflammation in asthma.
Martin RJ
J Allergy Clin Immunol; 2002 Feb; 109(2 Suppl):S447-60. PubMed ID: 11842317
[TBL] [Abstract][Full Text] [Related]
10. Linear growth and bone maturation are unaffected by 1 year of therapy with inhaled flunisolide hydrofluoroalkane in prepubescent children with mild persistent asthma: a randomized, double-blind, placebo-controlled trial.
Bensch GW; Greos LS; Gawchik S; Kpamegan E; Newman KB
Ann Allergy Asthma Immunol; 2011 Oct; 107(4):323-9. PubMed ID: 21962092
[TBL] [Abstract][Full Text] [Related]
11. Multiple-dose proportionality study of flunisolide hydrofluoroalkane.
Nolting A; Abramowitz W
Allergy Asthma Proc; 2002; 23(5):311-8. PubMed ID: 12476540
[TBL] [Abstract][Full Text] [Related]
12. Randomized trial of inhaled flunisolide versus placebo among asthmatic patients discharged from the emergency department.
Brenner BE; Chavda KK; Camargo CA
Ann Emerg Med; 2000 Nov; 36(5):417-26. PubMed ID: 11054193
[TBL] [Abstract][Full Text] [Related]
13. Airway remodeling-associated mediators in moderate to severe asthma: effect of steroids on TGF-beta, IL-11, IL-17, and type I and type III collagen expression.
Chakir J; Shannon J; Molet S; Fukakusa M; Elias J; Laviolette M; Boulet LP; Hamid Q
J Allergy Clin Immunol; 2003 Jun; 111(6):1293-8. PubMed ID: 12789232
[TBL] [Abstract][Full Text] [Related]
14. Flunisolide HFA for the treatment of asthma: an old friend reformulated.
Shafazand S; Colice G
Expert Opin Pharmacother; 2004 May; 5(5):1163-73. PubMed ID: 15155115
[TBL] [Abstract][Full Text] [Related]
15. Vascularity in asthmatic airways: relation to inhaled steroid dose.
Orsida BE; Li X; Hickey B; Thien F; Wilson JW; Walters EH
Thorax; 1999 Apr; 54(4):289-95. PubMed ID: 10092688
[TBL] [Abstract][Full Text] [Related]
16. Central airways remodeling in COPD patients.
Pini L; Pinelli V; Modina D; Bezzi M; Tiberio L; Tantucci C
Int J Chron Obstruct Pulmon Dis; 2014; 9():927-32. PubMed ID: 25214779
[TBL] [Abstract][Full Text] [Related]
17. Effects on small airway obstruction of long-term treatments with beclomethasone/formoterol hydrofluoroalkane (metered-dose inhaler) versus fluticasone/salmeterol (dry-powder inhaler) in asthma: a preliminary study.
Corda L; Gardenghi GG; Modina D; Montemurro LT; Novali M; Tantucci C
Allergy Asthma Proc; 2011; 32(6):29-34. PubMed ID: 22221427
[TBL] [Abstract][Full Text] [Related]
18. Eosinophil-associated TGF-beta1 mRNA expression and airways fibrosis in bronchial asthma.
Minshall EM; Leung DY; Martin RJ; Song YL; Cameron L; Ernst P; Hamid Q
Am J Respir Cell Mol Biol; 1997 Sep; 17(3):326-33. PubMed ID: 9308919
[TBL] [Abstract][Full Text] [Related]
19. Effects of the inhaled corticosteroids fluticasone propionate, triamcinolone acetonide, and flunisolide and oral prednisone on the hypothalamic-pituitary-adrenal axis in adult patients with asthma.
Sorkness CA; LaForce C; Storms W; Lincourt WR; Edwards L; Rogenes PR
Clin Ther; 1999 Feb; 21(2):353-67. PubMed ID: 10211538
[TBL] [Abstract][Full Text] [Related]
20. Hydrofluoroalkane-134A beclomethasone or chlorofluorocarbon fluticasone: effect on small airways in poorly controlled asthma.
Thongngarm T; Silkoff PE; Kossack WS; Nelson HS
J Asthma; 2005 May; 42(4):257-63. PubMed ID: 16032934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
